Financial News
Latest News about MRK
Recent news which mentions MRK
These 4 Dow Stocks Are Screaming Buys in 2022
January 25, 2022
From Motley Fool
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
From Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
From Benzinga
Britain To Test Merck - Ridgeback Biotherapeutics' COVID-19 Antiviral Pill In Hospitalized Patients
January 24, 2022
Tickers
MRK
From Benzinga
3 No-Brainer Healthcare Stocks to Buy Right Now for Less than $150
January 24, 2022
From Motley Fool
Benzinga Bulls And Bears Of The Past Week: ViacomCBS, Ford, Meta, Netflix, Microsoft, Tesla And More
January 22, 2022
From Benzinga
From Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
From MarketWatch
We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone
January 20, 2022
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
From Benzinga
Palantir’s Long-Term Bull Case Looks Compelling
January 19, 2022
From InvestorPlace
Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer
January 19, 2022
From Benzinga
Merck's Keytruda Manages To Cross The Finish Line In Liver Cancer Confirmatory Trial
January 19, 2022
Tickers
MRK
From Benzinga
3 Under-the-Radar COVID Stocks
January 19, 2022
From Motley Fool
CNBC's Final Trades: Wynn Resorts, Goldman Sachs, Berkshire Hathaway And This Pharma Major
January 19, 2022
From Benzinga
Omicron cases seem to have peaked in northeastern states, but national case tally is still at record levels and hospitals are slammed
January 18, 2022
From MarketWatch
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
January 18, 2022
From Benzinga
Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed
January 18, 2022
From Benzinga
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
From Motley Fool
How Do Pfizer's and Merck's COVID Pills Work?
January 16, 2022
From Motley Fool
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
From Motley Fool
Merck Snags Yet Another Indication for This Drug Combo
January 14, 2022
From Motley Fool
Why Agenus Stock Took Investors for a Wild Ride in 2021
January 12, 2022
From Motley Fool
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
January 12, 2022
From Benzinga
CNBC's Final Trades: Merck, Intel, Meta Platforms, Goldman Sachs And This Biopharma Stock
January 11, 2022
From Benzinga
Merck's Keytruda As Adjuvant Treatment Improves Disease-Free Survival In Lung Cancer Setting
January 10, 2022
Tickers
MRK
From Benzinga
3 Big FDA Approvals to Watch For in Q1 2022
January 09, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
